

February 2025
* Likely, but not yet confirmed by Neuralink, the patient, or the trial site.
“It gives me the ability to keep working.”
Mike Melgarejo is Neuralink patient 4. He has ALS and received his implant at Barrow Neurological Institute in Phoenix in February 2025 as part of the PRIME study.
Patient details come from the patient's own public posts, Neuralink, trial sites, and news reports. This page is general information about an investigational device and is not medical advice.
More publicly identified Neuralink patients